Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free ...

Budget 2025: Seeks to further amend notification No. 16/2017-Customs, dated the 20th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified ...

The Department of Pharmaceuticals (DoP) received a 28.82 per cent boost, with Rs 5,268.72 crore allocated. The promotion of ...

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...